Paul Jude Tonna, Director at BioRestorative Therapies, Inc. (BRTX), bought 120,000 shares at $0.25 ($30K) on 2014-08-01, disclosed to the SEC on 2014-08-08.
Open-market purchase of $30k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |